Maupas et al[88] |
34 |
1 mo |
Saccharomyces boulardii |
9 × 109
|
Improved stool number and consistency |
Gade et al[89] |
54 |
1 mo |
Paraghurt (Streptococcus faecium) |
1 × 10¹² |
Improved symptoms |
Halpern et al[90] |
18 |
4 mo |
Lactobacillus acidophilus |
2 × 1010
|
Improved symptoms |
O’Sullivan et al[91] |
25 |
1 mo |
Lactobacillus GG |
1 × 1010
|
No benefit |
Nobaek et al[92] |
60 |
1 mo |
Lactobacillus plantarum 299V Pro-Viva®
|
5 × 107
|
Improved global symptoms |
Niedzielin et al[93] |
40 |
1 mo |
Lactobacillus plantarum 299V Pro-Viva®
|
2 × 1010
|
Improved global symptoms |
Kim et al[94] |
25 |
2 d-IBS |
VSL3®
|
9 × 10¹¹ |
Reduced bloating |
Tsuchiya et al[95] |
68 |
3 mo |
Lactobacillus acidophilus |
1.5 × 106
|
Improved symptoms |
|
|
|
Lactobacillus helveticus |
1.3 × 109
|
|
|
|
Bifidobacterium |
4.95 × 109
|
O’Mahony et al[96] |
80 |
2 mo |
Bifidobacterium longum subspecies infantis vs Lactobacillus salivarius |
1 × 1010
|
B. infantis: improved global symptoms and anti-inflammatory cytokine profileLactobacillus salivarius: no benefit |
Kajander et al[97] |
103 |
6 mo |
Mixture (2 strains of Lactobacillus rhamnosus, Bifidobacterium breve, Propionibacterium freudenreichii) |
8-9 × 109
|
Improved global symptoms |
Bittner et al[98] |
25 |
0.5 mo |
29 bacteria + prebiotic Prescript-Assist®
|
2.6 × 108
|
Improved wellbeing |
Sen et al[99] |
12 |
1 mo |
Lactobacillus plantarum 299V Pro-Viva®
|
5 × 107
|
No benefit; Study design flawed |
Bausserman et al[100] |
50 |
1.5 mo |
Lactobacillus GG |
2 × 1010
|
No benefit |
Niv et al[101] |
39 |
6 mo |
Lactobacillus GG |
2 × 108
|
No benefit Francis severity IBS score |
Kim et al[102] |
48 |
1 or 2 mo |
VSL3®
|
8 × 109
|
Reduced flatulence, retarded colonic transit |
Whorwell et al[103] |
362 |
1 mo |
Bifidobacterium longum subspecies infantis 35 624 in 3 doses |
1 × 106
|
Improved global symptoms |
|
|
|
1 × 108
|
|
|
|
1 × 1010
|
Long et al[104] |
60 |
0.5 mo |
Bifidobacterium |
2 × 108
|
Symptoms resolved |
Gawrońska et al[105] |
104 |
1 mo |
Lactobacillus GG |
6 × 109
|
Reduced frequency of pain |
Moon et al[106] |
34 |
1 mo |
Bifidobacterium subtilis, Streptococcus faecium
|
750 mL/d, CFU/d not given |
Reduced frequency pain |
Marteau et al[107] |
116 |
1 mo |
Lactibiane® (4 strains of Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus lactis, Streptococcus thermophilus) |
1 × 1010
|
Reduced painIncreased colonic transit in those with constipation |
Simrén et al[108] |
76 |
1.5 mo |
Lactobacillus plantarum 299V |
2 × 109
|
No benefit |
Simrén et al[109] |
118 |
2 mo |
Lactobacillus paracasei ssp paracasei |
2 × 1010
|
No benefit |
Guyonnet et al[110] |
274 |
1.5 mo |
Bifidobacterium animalis, Streptococcus thermophilus and Lactobacillus bulgaricus
|
1.25 × 1010 1.2 × 109
|
Improved bloating and constipation |
Drouault-Holowacz et al[111] |
116 |
1 mo |
Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus lactis, Streptococcus thermophilus
|
1 × 1010
|
Not significant in relieving symptoms |
Sinn et al[112] |
40 |
1 mo |
Lactobacillus acidophilus |
2 × 108
|
Improved abdominal pain and discomfort |
Enck et al[113] |
297 |
1 mo |
Escherichia coli, Enterococcus faecalis
|
4.5 × 102
|
Improvement in pain |
Hun et al[114] |
44 |
2 mo |
Bacillus coagulans |
8 × 108
|
Improvement abdominal pain and bloating |
Dolin et al[115] |
61 |
2 mo |
Bacillus coagulans |
2 × 109
|
Diminution of diarrhea |
Ligaarden et al[116] |
16 |
1 mo |
Lactobacillus plantarum |
1010/L |
Worsening of symptoms |
Moayyedi et al[117] |
19 randomised controlled trials in 1650 patients |
|
|
|
Probiotics appear to be efficacious but the magnitude of benefit and the most effective strains are uncertain |